Adnexus Therapeutics Announces Appointment of Timothy J. Rink, MD, ScD to Its Board of Directors  
8/21/2007 10:51:18 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Adnexus Therapeutics, Inc. today announced Timothy J. Rink, MD, ScD has joined the Adnexus Board of Directors. Dr. Rink also currently serves as chairman of the Strategy Panel of the Technology Transfer division of the Wellcome Trust that funds biomedical research, and serves on the boards of Santhera Pharmaceuticals (SWX: SANN) and Sepracor, Inc. (NASDAQ: SEPR) and the scientific advisory board of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN).